/ Ad Scientiam, a global leader in digital biomarkers, has announced a partnership with Sanofi to launch MS-DETECT, an international, multicenter, longitudinal study. MS-DETECT aims to evaluate the ability of MSCopilot®, a medical software device, to detect early signs of
TripGift® Accelerates Gift Card Brand Portfolio to Industry-First 85 Currencies With Full Global Travel and Experience Redemption Range in Each Currency
Plotly Co-founder and former CEO creates Flojoy, the first no-code test, measurement software
New Software Release Exploits PCIe Gen 5 Technology, Allowing Users to Capture Maximum Performance While Maintaining Data Integrity and Security
In-depth Analysis and Testing Unveil the Leading Brain-Boosting Supplements
/ In addition to helping alleviate a chronic nursing shortage in the United States, immigrant nurses are estimated to spend well over $46 billion annually in the U.S. economy while providing hundreds of millions more in financial support to family
SupremeRAID™ by Graid Technology and Liqid IO Accelerators recognized for sophisticated software-composed solution that provides scalable storage and unprecedented levels of performance without sacrificing system integrity or security.
/ CanariaBio, a KOSDAQ-listed and a leading late-stage biotechnology company, announces the successful enrollment completion of a Phase 2 study of Oregovomab in combination with niraparib, GSK’s poly (ADP-ribose) polymerase (PARP) inhibitor, for treatment of patients with platinum-sensitive recurrent ovarian
This strategic acquisition greatly enhances Armor’s capabilities in cloud security and IT risk, delivering advanced solutions to its customers across US, EMEA, and Asia Pacific.
The Company Will Conduct an Investor Update Call on August 9 at 10:30am EST to Discuss its Progress and Growing Sales of its Plug & Play Smart and Standard Products, Financials, as Well as its Continuing Safety Standardization Progress
The Marketplace Experts Welcome Alex Pesjak and David Detjen to Lead Expanded European Operations
iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases. Manufacturing agreement supports advancement of iTolerance’s development of iTOL-100 towards first in human clinical study for lead program, iTOL-102.
ArtCap Strategies (“ArtCap”) is a fund specialized in direct lending throughout Latin America and the Caribbean
Historic Cowdray Park Polo Club Hosts Both Ladies and Gold Cup Championships
HanchorBio Received IND Approval of HCB101 Multi-Regional Clinical Trial By Taiwan FDA
/ BioGX, a global provider of easy molecular diagnostic solutions, announced accelerated adoption of their high performance Sample-Ready™ PCR assay* for detection of Candida auris, a rapidly spreading, hard to treat fungus with a growing presence in hospitals and long-term
/ On June 27, 2023, Piers Dunhill and the Dunhill Ventures team held a special event at London Climate Action Week in London, with a diverse portfolio of companies that are in the field of health and wellness, biotechnology research,
/ Today, at the margins of the U.S. Africa Financial Inclusion Conference sponsored by the U.S. Trade and Development Agency (USTDA), Brij Technologies, Inc. unveiled Paybills.Africa. The platform seamlessly connects Africa’s merchants globally, allowing customers to settle bills from anywhere
/ Aircraft Engine Lease Finance, Inc. (“AELF”) announced today that it has appointed Philip Scruggs to its Board of Directors. Scruggs brings more than 25 years of experience in the commercial aircraft leasing industry to the US-based leasing and trading
IPO News has just released an upcoming IPO Brochure section on its website. The IPO market has been slow this year but there are still some gems planning on coming to the market. This Private Company research website reports on